These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 28882176
1. Use of the mice passive protection test to evaluate the humoral response in goats vaccinated with Sterne 34F2 live spore vaccine. Phaswana PH, Ndumnego OC, Koehler SM, Beyer W, Crafford JE, van Heerden H. Vet Res; 2017 Sep 07; 48(1):46. PubMed ID: 28882176 [Abstract] [Full Text] [Related]
2. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model. Ndumnego OC, Köhler SM, Crafford J, van Heerden H, Beyer W. Vet Immunol Immunopathol; 2016 Oct 01; 178():14-21. PubMed ID: 27496738 [Abstract] [Full Text] [Related]
3. Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions. Koehler SM, Buyuk F, Celebi O, Demiraslan H, Doganay M, Sahin M, Moehring J, Ndumnego OC, Otlu S, van Heerden H, Beyer W. BMC Vet Res; 2017 Jul 12; 13(1):220. PubMed ID: 28701192 [Abstract] [Full Text] [Related]
4. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Welkos S, Little S, Friedlander A, Fritz D, Fellows P. Microbiology (Reading); 2001 Jun 12; 147(Pt 6):1677-1685. PubMed ID: 11390699 [Abstract] [Full Text] [Related]
5. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes. Chitlaru T, Israeli M, Rotem S, Elia U, Bar-Haim E, Ehrlich S, Cohen O, Shafferman A. Vaccine; 2017 Oct 20; 35(44):6030-6040. PubMed ID: 28342664 [Abstract] [Full Text] [Related]
6. Quantitative anti-PA IgG ELISA; assessment and comparability with the anthrax toxin neutralization assay in goats. Ndumnego OC, Crafford J, Beyer W, van Heerden H. BMC Vet Res; 2013 Dec 27; 9():265. PubMed ID: 24373579 [Abstract] [Full Text] [Related]
7. Immunogenicity of anthrax recombinant peptides and killed spores in goats and protective efficacy of immune sera in A/J mouse model. Ndumnego OC, Koehler SM, Crafford JE, Beyer W, van Heerden H. Sci Rep; 2018 Nov 16; 8(1):16937. PubMed ID: 30446695 [Abstract] [Full Text] [Related]
8. Immunogenicity of Non-Living Anthrax Vaccine Candidates in Cattle and Protective Efficacy of Immune Sera in A/J Mouse Model Compared to the Sterne Live Spore Vaccine. Jauro S, Ndumnego OC, Ellis C, Buys A, Beyer W, Heerden HV. Pathogens; 2020 Jul 10; 9(7):. PubMed ID: 32664259 [Abstract] [Full Text] [Related]
9. Evaluation of the protective efficacy of recombinant protective antigen vaccine (GC1109)-immunized human sera using passive immunization in a mouse model. Jo SK, Ahn BE, Choi EH, Kang JE, An H, Oh MD, Rhie GE. Vaccine; 2020 Feb 11; 38(7):1586-1588. PubMed ID: 31911031 [Abstract] [Full Text] [Related]
10. Immunological correlates for protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits. Weiss S, Kobiler D, Levy H, Marcus H, Pass A, Rothschild N, Altboum Z. Infect Immun; 2006 Jan 11; 74(1):394-8. PubMed ID: 16368995 [Abstract] [Full Text] [Related]
11. Comparisons of the humoral and cellular immunity induced by live A16R attenuated spore and AVA-like anthrax vaccine in mice. Lv J, Zhang YY, Lu X, Zhang H, Wei L, Gao J, Hu B, Hu WW, Hu DZ, Jia N, Feng X. Biologicals; 2017 Mar 11; 46():130-138. PubMed ID: 28215694 [Abstract] [Full Text] [Related]
12. Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge. Sivko GS, Stark GV, Tordoff KP, Taylor KL, Glaze E, VanRaden M, Schiffer JM, Hewitt JA, Quinn CP, Nuzum EO. Vaccine; 2016 Dec 12; 34(51):6518-6528. PubMed ID: 27155494 [Abstract] [Full Text] [Related]
13. Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice. Welkos SL, Friedlander AM. Microb Pathog; 1988 Aug 12; 5(2):127-39. PubMed ID: 3148815 [Abstract] [Full Text] [Related]
15. Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine. Zeng M, Xu Q, Pichichero ME. Vaccine; 2007 May 04; 25(18):3588-94. PubMed ID: 17293013 [Abstract] [Full Text] [Related]
16. Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization. Herrmann JE, Wang S, Zhang C, Panchal RG, Bavari S, Lyons CR, Lovchik JA, Golding B, Shiloach J, Lu S. Vaccine; 2006 Jul 26; 24(31-32):5872-80. PubMed ID: 16790303 [Abstract] [Full Text] [Related]
17. Vaccine-induced protection against anthrax in cheetah (Acinonyx jubatus) and black rhinoceros (Diceros bicornis). Turnbull PC, Tindall BW, Coetzee JD, Conradie CM, Bull RL, Lindeque PM, Huebschle OJ. Vaccine; 2004 Sep 03; 22(25-26):3340-7. PubMed ID: 15308358 [Abstract] [Full Text] [Related]
18. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits. Wimer-Mackin S, Hinchcliffe M, Petrie CR, Warwood SJ, Tino WT, Williams MS, Stenz JP, Cheff A, Richardson C. Vaccine; 2006 May 01; 24(18):3953-63. PubMed ID: 16530302 [Abstract] [Full Text] [Related]
19. In Vitro Protection and Titer Duration of Anthrax-Specific Antibodies Following Subcutaneous Vaccination of White-tailed Deer (Odocoileus virginianus) with Bacillus anthracis Sterne 34F2 Strain Spores. Nunez CM, Benn JS, Blue-McLendon A, Chaki SP, Ficht TA, Rice-Ficht AC, Cook WE. J Wildl Dis; 2024 Jan 01; 60(1):179-183. PubMed ID: 37921658 [Abstract] [Full Text] [Related]